LC002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LC002, covering 2011-10-13 to 2011-10-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART [Phase 1, Phase 2]